Cargando…
COVID‑19 antibody production by vaccination in chemotherapy with CD20 antibody for B‑cell lymphoma
Most hematologic diseases are immunosuppressed, either by the disease itself or by treatment. As such, the implementation of vaccination is largely at the discretion of the attending physician. In this context, an objective measure is needed, therefore the index of vaccination against coronavirus di...
Autores principales: | Tsutsumi, Yutaka, Ito, Shinichi, Horikita, Fuka, Moriki, Asako, Teshima, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619194/ https://www.ncbi.nlm.nih.gov/pubmed/37920416 http://dx.doi.org/10.3892/mco.2023.2692 |
Ejemplares similares
-
5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report
por: Tsutsumi, Yutaka, et al.
Publicado: (2016) -
Ibrutinib Caused Mediastinal Emphysema and Pneumothorax in the Treatment of a Patient with Mantle Cell Lymphoma
por: Tsutsumi, Yutaka, et al.
Publicado: (2019) -
Patients with marginal zone dural lymphoma successfully treated with rituximab and bendamustine: A report of two cases
por: Tsutsumi, Yutaka, et al.
Publicado: (2021) -
A Rare Case of BCL2-Positive Multiple Myeloma Complicated with Follicular Lymphoma
por: Tsutsumi, Yutaka, et al.
Publicado: (2022) -
Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection
por: Tsutsumi, Yutaka, et al.
Publicado: (2023)